Ambrx Biopharma Inc. Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests
Ambrx Biopharma Inc. reported Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests of $15.70 million for the 1-month period ending 2021-04-30, per its 10-K filed 2023-03-30.
Discontinued › Shareholders' Equity
us-gaap:MinorityInterestDecreaseFromRedemptions · last filed 2023-03-30
- 2021-04-30: Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 1 month $15.70M.
| Period end | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 1 month |
|---|---|
| 2021-04-30 | $15.70M 10-K · filed 2023-03-30 |